Van Hulzen Asset Management, LLC Jazz Pharmaceuticals PLC Transaction History

Van Hulzen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $14,139 - $17,423	109 Added 4.32%	2,631 $419,000
Q3 2022 Nov 08, 2022	SELL	$126.59 - $161.18 $398,125 - $506,911	-3,145 Reduced 55.5%	2,522 $336,000
Q2 2022 Aug 04, 2022	SELL	$141.59 - $168.66 $58,335 - $69,487	-412 Reduced 6.78%	5,667 $884,000
Q1 2022 May 20, 2022	BUY	$129.64 - $160.7 $26,835 - $33,264	207 Added 3.53%	6,079 $946,000
Q4 2021 Feb 04, 2022	BUY	$119.87 - $145.67 $131,257 - $159,508	1,095 Added 22.92%	5,872 $748,000
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $248,403 - $356,829	1,931 Added 67.85%	4,777 $622,000
Q2 2021 Aug 06, 2021	BUY	$160.2 - $186.42 $30,277 - $35,233	189 Added 7.11%	2,846 $506,000
Q1 2021 May 12, 2021	BUY	$150.19 - $173.5 $6,007 - $6,940	40 Added 1.53%	2,657 $437,000
Q4 2020 Feb 16, 2021	BUY	$140.71 - $165.05 $13,789 - $16,174	98 Added 3.89%	2,617 $432,000
Q3 2020 Nov 03, 2020	BUY	$105.46 - $144.13 $265,653 - $363,063	2,519 New	2,519 $359,000
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $917,760 - $1.6 Million	-10,460 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$117.65 - $153.73 $1.23 Million - $1.61 Million	10,460 New	10,460 $1.56 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.